» Articles » PMID: 26380326

Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases

Overview
Journal J Immunol Res
Publisher Wiley
Date 2015 Sep 18
PMID 26380326
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Almost all cells and organisms release membrane structures containing proteins, lipids, and nucleic acids called extracellular vesicles (EVs), which have a wide range of functions concerning intercellular communication and signaling events. Recently, the characterization and understanding of their biological role have become a main research area due to their potential role in vaccination, as biomarkers antigens, early diagnostic tools, and therapeutic applications. Here, we will overview the recent advances and studies of Evs shed by tumor cells, bacteria, parasites, and fungi, focusing on their inflammatory role and their potential use in vaccination and diagnostic of cancer and infectious diseases.

Citing Articles

Exosomes in infectious diseases: insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential.

Abida , Alhuthali H, Alshehri J, Alkathiri A, Almaghrabi R, Alsaeed S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39702600 DOI: 10.1007/s00210-024-03702-7.


Potential of extracellular vesicles in the pathogenesis, diagnosis and therapy for parasitic diseases.

Pinheiro A, Torrecilhas A, Souza B, Cruz F, de Matos Guedes H, Ramos T J Extracell Vesicles. 2024; 13(8):e12496.

PMID: 39113589 PMC: 11306921. DOI: 10.1002/jev2.12496.


Boron Neutron Capture Therapy-Derived Extracellular Vesicles via DNA Accumulation Boost Antitumor Dendritic Cell Vaccine Efficacy.

Lv L, Zhang J, Wang Y, Liang H, Liu Q, Hu F Adv Sci (Weinh). 2024; 11(35):e2405158.

PMID: 39021327 PMC: 11425286. DOI: 10.1002/advs.202405158.


Guidelines for the purification and characterization of extracellular vesicles of parasites.

Fernandez-Becerra C, Xander P, Alfandari D, Dong G, Aparici-Herraiz I, Rosenhek-Goldian I J Extracell Biol. 2024; 2(10):e117.

PMID: 38939734 PMC: 11080789. DOI: 10.1002/jex2.117.


Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer.

Gardani C, Pedrazza E, Paz V, Zanirati G, Da Costa J, Andrejew R Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004484 PMC: 10675019. DOI: 10.3390/ph16111619.


References
1.
Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Scorza F . Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles. 2013; 2. PMC: 3760637. DOI: 10.3402/jev.v2i0.20181. View

2.
Kadurugamuwa J, Beveridge T . Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacteriol. 1995; 177(14):3998-4008. PMC: 177130. DOI: 10.1128/jb.177.14.3998-4008.1995. View

3.
Soares R, Torrecilhas A, Assis R, Rocha M, Moura e Castro F, Freitas G . Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues. Am J Trop Med Hyg. 2012; 87(1):87-96. PMC: 3391063. DOI: 10.4269/ajtmh.2012.12-0015. View

4.
Shimbo K, Miyaki S, Ishitobi H, Kato Y, Kubo T, Shimose S . Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun. 2014; 445(2):381-7. DOI: 10.1016/j.bbrc.2014.02.007. View

5.
Wylie C, Carbonell-Antonanzas M, Aiassa E, Dhollander S, Zagmutt F, Brodbelt D . A systematic review of the efficacy of prophylactic control measures for naturally-occurring canine leishmaniosis, part I: vaccinations. Prev Vet Med. 2014; 117(1):7-18. DOI: 10.1016/j.prevetmed.2014.06.015. View